Xu Cao
- Molecular Biology
- Cancer Research top 10%
- Epidemiology
- Oncology
- Hepatology top 10%
- Topics
- Liver Disease Diagnosis and Treatment (11 papers)Hepatitis B Virus Studies (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xu Cao
61 papers receiving 772 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 381
- Cancer Research 197
- Epidemiology 163
- Oncology 161
- Hepatology 100
Countries citing papers authored by Xu Cao
This map shows the geographic impact of Xu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Cao more than expected).
Fields of papers citing papers by Xu Cao
This network shows the impact of papers produced by Xu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Cao. The network helps show where Xu Cao may publish in the future.
Co-authorship network of co-authors of Xu Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Cao. A scholar is included among the top collaborators of Xu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Cao. Xu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 7 | |
| 10 | 16 | |
| 11 | 5 | |
| 12 | 12 | |
| 13 | 5 | |
| 14 | 3 | |
| 15 | 10 | |
| 16 | 63 | |
| 17 | 33 | |
| 18 | 2 | |
| 19 | [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer]. | 4 |
| 20 | 18 |
About Xu Cao
Xu Cao is a scholar working on Hepatology, Cancer Research and Issues, ethics and legal aspects, having authored 64 papers that have together received 780 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (197 citations), Hepatology (100 citations) and Oncology (161 citations). Xu Cao has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiaoke Li, Yongan Ye, Hongbo Du, Guang Chen, Jiaying Zhang, Jiaxin Zhang, Danan Gan, Peng Zhang, Mei Han and Qiuling Fan. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.